Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?

Grabie, M; Tai, CH; Frishman, WH

Frishman, WH (reprint author), New York Med Coll, Dept Med, 40 Sunshine Cottage Rd, Valhalla, NY 10595 USA.

CARDIOLOGY IN REVIEW, 2019; 27 (5): 242

Abstract

Cholesterol metabolism and transport has been a major focus in cardiovascular disease risk modification over the past several decades. Hydroxymethylgl......

Full Text Link